Read the docs
TI-2022-22508 Aliases CVE-2022-45611GHSA-7qc3-f88f-rqhv

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain…

Priority MEDIUM 51CWE-522Published · Updated

Key facts

Attack vector
Network
Privileges required
None
User interaction
None
Attack complexity
Low
Impact type
Information disclosure
Confidentiality · integrity · availability
High · High · High
Fix status
No fix listed

Attack profile from CVSS 3.1 · NVD. Fix status from CNA. Impact type from CWE-522.

Summary

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.01177 67th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
Yes
Technical impact
Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 2

CPEVersionsRoleVendor
cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*5.1.759.0VulnerableFresenius Kabi
cpe:2.3:h:fresenius-kabi:pharmahelp:-:*:*:*:*:*:*:*not specified by NVDRunning onFresenius Kabi
  • cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:* Versions 5.1.759.0 Vulnerable ·Fresenius Kabi
  • cpe:2.3:h:fresenius-kabi:pharmahelp:-:*:*:*:*:*:*:* Versions not specified by NVD Running on ·Fresenius Kabi

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2022-45611
  2. 2026-10-03 Alias added: GHSA-7qc3-f88f-rqhv

References

Other 3

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences